Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Armstrong

Showing results (81-90 of 281) with videos related to

Pageof 29
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1984
Pharmacokinetic-hemodynamic studies of disopyramideH Abdollah, J F Brien, P W Armstrong
Peptides|January 1, 1994
Measurement of angiotensin II: use of two injectors to minimize HPLC shadowingG O Naik, C Forster, P W Armstrong
La Nouvelle Presse Medicale|September 25, 1980
Pharmacokinetic-hemodynamic studies of nitroglycerin in congestive cardiac failureP W Armstrong, J A Armstrong, G S Marks
Cardiovascular Research|June 1, 1991
Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failureR J Howard, G W Moe, P W Armstrong
Chest|January 1, 1987
Calcium antagonists: new therapy for congestive heart failure?C A Lefkowitz, G W Moe, P W Armstrong
Lancet (London, England)|December 16, 2000
Intracranial haemorrhage with bolus thrombolytic agentsP W Armstrong, C Granger, F Van de Werf
Journal of Pharmaceutical and Biomedical Analysis|March 15, 2001
Specific and non-specific measurements of tissue angiotensin II cascade membersG O Naik, G W Moe, P W Armstrong
Circulation|February 27, 2001
Bolus fibrinolysis: risk, benefit, and opportunitiesP W Armstrong, C Granger, F Van de Werf
British Journal of Clinical Pharmacology|October 1, 1983
Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failureP W Armstrong, D G Watts, J A Moffat
Circulation|October 31, 2001
Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001T Fleming, J Borer, R Lipicky, et al.
Pageof 29

Showing results (81-90 of 281) with videos related to

Sort By:
Pageof 29
Journal of Cardiovascular Pharmacology|January 1, 1984
Pharmacokinetic-hemodynamic studies of disopyramideH Abdollah, J F Brien, P W Armstrong
Peptides|January 1, 1994
Measurement of angiotensin II: use of two injectors to minimize HPLC shadowingG O Naik, C Forster, P W Armstrong
La Nouvelle Presse Medicale|September 25, 1980
Pharmacokinetic-hemodynamic studies of nitroglycerin in congestive cardiac failureP W Armstrong, J A Armstrong, G S Marks
Cardiovascular Research|June 1, 1991
Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failureR J Howard, G W Moe, P W Armstrong
Chest|January 1, 1987
Calcium antagonists: new therapy for congestive heart failure?C A Lefkowitz, G W Moe, P W Armstrong
Lancet (London, England)|December 16, 2000
Intracranial haemorrhage with bolus thrombolytic agentsP W Armstrong, C Granger, F Van de Werf
Journal of Pharmaceutical and Biomedical Analysis|March 15, 2001
Specific and non-specific measurements of tissue angiotensin II cascade membersG O Naik, G W Moe, P W Armstrong
Circulation|February 27, 2001
Bolus fibrinolysis: risk, benefit, and opportunitiesP W Armstrong, C Granger, F Van de Werf
British Journal of Clinical Pharmacology|October 1, 1983
Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failureP W Armstrong, D G Watts, J A Moffat
Circulation|October 31, 2001
Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001T Fleming, J Borer, R Lipicky, et al.
Pageof 29